Pablo Michel Sanchez, MD
Cardiovascular Disease · Coeur D Alene, IDNPI 1053845305
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $433 of the $638 with a category attached, or 67.8%. 6 manufacturers reported payments, led by Boston Scientific at 40.0% of the total. Reporting peaked in 2024 at $361 and has fallen 93.5% since, to $23 in 2025. That places this record below the midpoint for cardiovascular disease clinicians in ID, where the typical reported total is $1,233.
Across 9 payments — averaging $70.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$255
- Abbott$205
- E.r. Squibb & Sons, L.L.C.$87
- Medtronic$42
- Edwards Lifesciences$25
- Sanofi$23
What the payments were for
- Food & beverage$43368%
- Education$20532%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 3 | $255 |
| Abbott | 1 | $205 |
| E.r. Squibb & Sons, L.L.C. | 1 | $87 |
| Medtronic | 2 | $42 |
| Edwards Lifesciences | 1 | $25 |
| Sanofi | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE$205
- PatientCare Link$131
- WATCHMAN FLX$109
How this compares
$638 in reported general payments places this provider in the 30th percentile of 59 cardiovascular disease providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 100 | $105,006 |
| JardianceEmpagliflozin | 43 | $59,752 |
| EntrestoSacubitril/Valsartan | 31 | $35,964 |
| Repatha SureclickEvolocumab | 16 | $24,735 |
| XareltoRivaroxaban | 18 | $24,480 |
| CorlanorIvabradine Hcl | 14 | $13,752 |
| BrilintaTicagrelor | 12 | $7,631 |
| Colchicine | 11 | $2,860 |
| Metoprolol Succinate | 106 | $1,557 |
| Rosuvastatin Calcium | 60 | $831 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 19 | $695 |
| Amiodarone Hcl | 21 | $686 |
| Atorvastatin Calcium | 63 | $636 |
| Ezetimibe | 19 | $554 |
| Valsartan | 45 | $554 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Coeur D Alene
- Ronald FritzCoeur D Alene$17K
- Shawn TaylorCoeur D Alene$3K
- Giselle StatzCoeur D Alene$681
- Aaron NotestineCoeur D Alene$141
- Edward MacinerneyCoeur D Alene$51
- David HinchmanBoise$324K
- Jacob DelarosaPocatello$226K
- David LaxsonKetchum$135K
- Ryan LongmorePocatello$60K
- Robyn BrydeBoise$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.